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Several studies have demonstrated the presence in serum of antibodies to hereditary 
q'-globulin factors (Gm) in man. A high incidence of anti-Gin antibody was found in 
the sera of patients following multiple  (1) and even single  (2) blood transfusions, and 
in patients  receiving "}'-globulin injections  for allergy  or slight hypogammaglobulin- 
emia (3).  Furthermore,  dellberate immunization of man has also been shown to lead 
to the production of antibody to Gm factors (3). 
Gamma G globulins which carry the Gm antigens have been shown in man to cross 
the maternal fetal barrier in both directions  (4).  Therefore,  Gm incompatibility be- 
tween mother and fetus could lead to anti-Gin production by the mother in a manner 
analogous to the production of anti-Rh  antibodies  in an Rh negative mother of an 
Rh positive child; and/or it could lead to production of antibody in the child directed 
against maternal  Gm  factors  (SNagg).  Evidence for  each  of  these possibilities  has 
recently been advanced (5-9). A similar result has been observed in pigs, in that some 
sera from normal pigs were found to contain antibodies to T-globulin isoantigens, pre- 
sumably resulting from immunization with maternally derived incompatible 3'-globu- 
lin (10). 
In view  of the present  detailed  knowledge  of  the  multiple  antigenic  speci- 
fieities of mouse allotypic antigens (11-15) and the  availability  of many inbred 
mouse strains,  it was felt that a study of the possible consequences of maternal 
fetal  incompatibility  of  the  immunoglobulin  allotypes  could  be  undertaken 
in  this  species.  Since  maternal  3'-G globulin  not  only crosses  the  placenta  in 
mice  but  also crosses  the gut until  the young are  about  16  days  of age  (16), 
and  since  newborn  mice  can  be  rendered  tolerant by neonatal  injection  with 
appropriate  doses  of  some  antigens  (17-19),  particular  emphasis  was  placed 
in this study on examining the recipients  for both  tolerance  and immunity to 
the maternally derived immunoglobulins. 
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Materials and Methods 
Mice.--Mice  of  the  inbred  strains C57B1/10Hz,  BALB/cCrgl/Ga, B10.D2  (C57B1/10- 
H2 d),  129/J, and DBA/2 were from colonies maintained in this laboratory. Hybrid mice of 
the cross (C57B1/6 X  A/J) were obtained from the Jackson Laboratories, Bar Harbor, Maine. 
Maintenance of Mice.--Breeding of various crosses of inbred strains and foster nursing of 
various progeny mice were performed as previously described (20). Serum samples were taken 
at various intervals by incision of the tail artery; after clot retraction, sera were separated and 
stored  at  --20°C. 
Allotypes.--The  strains used  in  these experiments have  the following immunoglobulin 
allotypes: Ig-I~BALB/c, 129/J; Ig-lb-B10.D~,  C57B1/6,  C57B1/10;  Ig-I~-DBA/2; Ig-1  ~- 
A/J (11). 
Experimental Groups.--Three separate groups of strain combinations were used in these 
experiments. 
1.  Female (C57B1/6  >(  A/J)F1 mice were mated to male I)BA/2 mice and the progeny 
bled at various intervals after weaning. 
2.  A combined group of mice were all tested for the production of anti-Ig-la: (a)  Female 
(BALB/c  X  B10.D2)F1,  mated  to  male  C57B1/10Hz  (female previously immunized  to 
129/J spleen cells for production of anti-H-2b); (b) Inbred C57B1/10 or B10.D2 foster nursed 
on 129/J or BALB/c females immune to H-2d; (c) Inbred C57B1/10 or B10.D2  foster nursed 
on normal 129/J or BALB/c females. 
The progeny from groups (a), (b), and (c) were bled for serum at various intervals and tested 
for anti-Ig-1  a  antibody.  Since no significant difference was observed between these three 
groups,  the results are pooled from these mice. 
3.  Female BALB/c mice were mated to 129/J males. At birth one-half of each litter were 
foster nursed on C57B1/10 females and the other half returned to the original BALB/c mother. 
At 6 wk of age all animals were injected with 10/zl of a C57B1/10 anti-H-2 d serum emulsified 
in complete Freund's adjuvant, and at 8 and 9 wk each animal received 20/zl of the same 
serum intraperitoneally. At 10 wk of age all animals were bled for serum. From 12-18 wk of 
age, approximately half of the animals which had failed to respond to the immunizing injec- 
tion of C57B1/10  anti-H2 d by producing anti-Ig-lb antibody, were given weekly injections 
of 10/zl of C57B1/10 serum intrapetitoneally. At 19, 21, and 22 wk the immunizing injection 
of C57B1/10  anti-H2 d serum was repeated and all mice were bled at 23 wk of age. 
Serological Techniques.--Screening  for progeny Ig-1 b immunoglobulin was done by agar 
gel diffusion with a potent anti-Ig-1 b serum raised in BALB/c mice by immunization with a 
C57B1/10  anti-H-2 d  serum. 
Detection of Immunoglobulin Allotype Antigens in Serum.--Specific  assays for determining 
the presence of Ig-1 a, Ig-1 b, and Ig-1  ° globulin were set up with the inhibition of precipitation 
of  125I-labeled immunoglobulin technique as previously described (11, 12,  15)  using specific 
alloantisera to appropriate allotypic antigens. 
Detection of Alloantibodies.--Sera  were tested for their ability to  precipitate  125I labeled 
immunoglobulin of appropriate allelic type by the previously described method (11, 12,  15). 
In all cases 5/zl of test serum were used and each serum sample was repeatedly tested on three 
to five different occasions. 
[mmunoglobulin  Preparations. Purified  immunoglobulins  for  the  above  assays  were 
prepared by either agar-block electrophoresis (pH 8.2 in Veronal buffer) from normal C57B1/10 
serum (for Ig-1 b) or by starch-block electrophoresis from myeloma-containing serum (RPC-5 
line for Ig-1 a and GPC-7 for Ig-1 e [12]). All proteins were iodinated by the method of Green- 
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RESULTS 
Sponta~eous Antibody Formation in Intercross Progeny.--In the first  experi- 
mental  group,  (C57B1/6  X  A/J)F~  females  were  mated  to  DBA/2  males: 
C57B1/6  =  Ig-1  b, A/J  --  Ig-1  e, DBA/2  =  Ig-1  e. Progeny were  bled  at 8  wk 
of age  and  the  sera  tested  in  Ouchterlony  agar  gel  diffusion  against  specific 
anti-Ig-1  b and anti-Ig-1  ° antisera.  On the basis  of these reactions  18 out of 31 
mice  were  identified  as  genotype  b/c  and  the  remaining  13  shown  to  be 
genotype e/c. Further serum samples were taken from each mouse at 13,  17-21, 
26, 32, 38, and 46 wk of age, and all samples were then tested/or  the presence 
of  antibodies  to  the  allotype  of  maternal  T-globulin  not  synthesized  by  the 
progeny mice, i.e., b/c mice tested for anti-e, and e/c mice tested for anti-b. 
TABLE I 
~c~ence~An~bo~to Mat~ndlyDeriv~Incompatiblev-~obulin m ~tercross Mice 
Total  Mice with antibody,  at ageforbleedingforserum,  wk:  Progeny (Ig-1)  No.  of 
genotype  mice  13  17  18  19  20  21  26  32  38  46 
b/c  18  O*  7  33  39  35  19  42  43  --  35 
e/c  13  15"  38  61  75  50  36  50  22  11  11 
b/cand e/c  31  10~  25  48  55  58  58  62  62  62  62 
* Per cent of mice with antibody at particular  serum sample. 
Cumulative  per cent of mice of both groups with  antibody at or before the particular 
serum sample. 
The data in Table I  show that 56 %  and 77 %  of mice of the two genotypes 
make antibody to the incompatible maternal type "y-globulin at some stage in 
their  life.  The  titers  produced  by  these  ammals,  however,  were  quite  low, 
which made it necessary to do extensive testing of each serum before classifying 
it as positive. Addition of the maximum permissible amount of test serum  (5#1) 
only precipitated  between  8  and  25 %  of the  labeled  antigen,  therefore  each 
serum  sample  was  tested  three  to five  times.  If  a  serum  sample  gave  more 
than  8 %  precipitation  of the labeled  antigen  on two or more out of three  or 
four tests, or three or more out of five tests, it was scored as containing antibody. 
The  degree  of precipitation  of the  Ig-1  e antigen  by sera  from  the  b/c  mice 
was in general lower than that of the Ig-1  b antigen by sera from the e/c mice. 
Samples of the strongest antisera were pooled and tested for antibody activity 
in Ouchterlony gel diffusion but no precipitation  lines were ever  observed. 
The sera from the e/c mice were  also assayed for the presence of  maternal 
Ig-1  b globulin. Levels were related to a standard pool of adult C57B1/10 serum 
where 0.2 %  of the standard  (0.02  mg/ml)  or greater  indicates  the  significant 
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high just after weaning, declines rapidly at first, and then  more slowly until it 
is below the threshold for detection. The  age  of mice at this disappearance of 
maternal  antigen  varies between  6  and  12  wk.  Appearance  of  antimaternal 
TABLE II 
Incidence  of Antibody to Maternally Derived Incompatible  "y-Globulin in Back-Cross  and Foster- 
Nursed Mice 
Age of mice at serum sample, wk: 
7  8  9  10  11  12  13 
No. of mice tested  48  45  49  24  28  25  14 
No. of mice with maternal antigen  30  20  13  2  1  0  0 
No. of mice with antibody  2  4  10  7  6  7  1 
Per cent of mice with antibody  4  11  20  29  22  28  7 
Cumulative per cent of mice with anti-  3  10  22  22  32  32  34 
body 
TABLE III 
Tolerance to Ig-lb Induced  by Presence of Maternal  Immunoglobulin 
Age (wk) 
0-3  6-9  9-16  19-22 
Allotype  Chal-  Responded  Chal-  Re-  sponded  of  Allotype nursed on  lenged*  with  Ig-lb level  lenged  with 
progeny  with Ig-lb  anti-Ig-lb  with Ig-lb  anti-Ig-lb 
Ig-la~  Ig-la (natural  40  40 
mother) 
Ig-la  Ig-lb§ (foster  33  0  Maintainedl]  14  1 
mother) 
Allowed to decay¶  15  15 
* Ig-lb challenge protocol: day 1, 10/zl C57B1/6 anti-H-2  a antiserum presented subcuta- 
neously in Freund's adjuvant; days 21 and 28, 20/zl of same antiserum diluted to 0.2 ml in 
phosphate-buffered saline; serum drawn for test at day 35. 
:~ (BALB/c X  129)F1 animals (Ig-la/Ig-la)  were used. 
§ C57B1/10, (Ig-lb) foster mothers were used. 
I[ Maintenance dose of 10/~I of normal C57B1/6 serum given at 10-12, 14 and 16 wk. 
¶ Half-life  of Ig-la is approximately  S days. 
allotype  antibody  generally  follows  the  disappearance  of  maternal  allotype 
by 1-2 wk. 
Serum samples taken between 6  and 15 wk of age from the b/b progeny of a 
back-cross of female b/a  X  male b/b  and from foster-nursed inbred b/b mice 
nursed  on Ig-P mothers were tested for Ig-la and for anti-Ig-la. Since both 
groups  showed similar results, the data were combined for presentation here. 444  TOLERANCE  AND  IMMUNITY  TO  MATERNAL  IMMUNOGLOBULINS 
The  cumulative  percentage  of  mice  producing  antibody  to  the  maternal 
allotype rises from 3 % at 7 wk to 32 % at 11 wk and 34% at 13 wk. The number 
of mice making antibody at any given test is highest at about 10-12 wk (Table 
II). 
Tolerance prior to  Production  of Antibody  1o  Maternal  Allotype.--73  Ig-1  ~ 
(BALB/c)  newborns  were  divided  into  two  groups;  one  group  nursed  on 
natural  Ig-D mothers and the other  on  Ig-1  b (C57B1/10)  foster mothers. At 
6,  8,  and 9  wk both groups were challenged with Ig-1 b. All of those  (40/40) 
nursed  on Ig-1  ~ mothers  (and  therefore having  no  circulating Ig-1  b)  gave  a 
strong  anti-Ig-1 b response.  However,  none  (0/33)  of  the  animals nursed on 
Ig-1  b mothers made detectable antibody (Table III). The latter, nonresponding 
group was then divided again; 14 animals were given maintenance injection of 
Ig-1  ~ (10/,1 of C57Bl/10 serum, intraperitoneally) and  15 controls were given 
10 •1  of BALB/c serum weekly. The remaining 4 animals had died. At 19, 21, 
and  22  wk,  all  animals  were  again  challenged with  Ig-1  b.  Only  1  of  the  14 
whose serum level of Ig-1  b had  been maintained made detectable anti-Ig-1  b, 
whereas all of the controls were now able to make a normal, strong anti-Ig-1 b 
response. 
DISCUSSION 
The newborn mammal is apparently protected from a variety of pathogens 
in its environment by a legacy of maternal immunoglobulins. These immuno- 
globulins, transferred either across the placenta, across the gut during nursing, 
or by both routes, stay around for the first few weeks of life; during this time 
the animal is able to build up a  competent immunity system, rendering him 
immunologically self-sufficient. This  survival  advantage,  however,  would  be 
seriously compromised if the immunoglobulins were polyTnorphic and  if they 
themselves were immunogenic (i.e., if they carried allotypes) unless the offspring 
were unable to respond to (were tolerant of) the incompatible maternal globu- 
lins, since an antibody response to maternal immunoglobulins would lead very 
rapidly to their elimination. In other words, here is a  natural situation where 
tolerance to a foreign protein antigen is essential if a genetic polymorphism is 
to be maintained,  or conversely, where a genetic polymorphism makes neces- 
sary the development of a system of tolerance to foreign antigen. 
As  the  data in  this  paper show,  the young mouse behaves toward the in- 
compatible immunoglobulin received from his mother in  the same way as he 
does  toward  other foreign soluble protein antigens  introduced at  birth  (22); 
as long as the level of antigen is high enough to maintain tolerance, he will not 
respond with antibody production, even if additional antigen is presented in 
what  would  otherwise  be  a  strongly  immunizing  regimen.  Once  the  antigen 
level drops below that necessary to maintain tolerance, he shows a  transient, 
weak antibody response and is then able to mount a strong immune response 
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It is likely that human infants exposed to incompatible maternal immuno- 
globulins  undergo  the  same  sequence  of  events.  Steinberg  and  Wilson  (6) 
have reported that individuals who produce antibody (SNagg) to Gin or Inv 
determinants on human gamma globulins in the absence of an external stimulus 
(for  example,  transfusion)  were  exposed  to  incompatible maternal  globulin. 
Speiser  (9),  using the  prospective  approach,  showed that  a  very large  per- 
centage (probably close  to  i00%,  considering the difficulties in detection)  of 
normal infants exposed  to  incompatible maternal gamma globulins have  at 
least a weak transient antibody response to these globulins sometime between 
3 months and 3 yr of age. This correlates well with our studies in mice where 
roughly 60%  of mice  at risk  showed naturally occurring antimaternal anti- 
body. Considering the difficulties, as in Speiser's study, of substantiating the 
relatively weak antibody responses, this 60 % must be taken as a low estimate, 
the true incidence probably being closer to 100 %. 
Our demonstration of tolerance before formation of antimaternal antibody 
in mice appears to contradict Steinberg and Wilson, who state that in untrans- 
fused SNagg  donors  "it  seems  probable  that.., immune  tolerance  has  not 
resulted from the presence of the (maternal) antigen in large quantity prior to 
and immediately after birth" (5). The contradiction is resolved, however, when 
one recognizes that tolerance to an antigen persists only as long as the antigen 
persists (22, 23),  and therefore, that finding antibody production in an animal 
reveals nothing about whether the animal had been tolerant previously. 
The  direct demonstration of tolerance before  the  emerging immune state 
in newborn children is clearly impractical. The generalization about man from 
our findings in mice, however, is strongly supported by the data of both Stein- 
berg and Wilson (6) and Speiser (8, 9) on the timing of antimaternal antibody 
production. The immunologic question still to be answered is why some, and 
not other, humans persist in producing good titers of antimaternal globulins 
well into adulthood in the apparent absence of additional exposure to antigen. 
SUMMARY 
Progeny mice were confronted with maternal'r-globulin of a different allotype 
by  either  back-cross  mating,  intercross mating,  or  by foster nursing.  In all 
cases,  many mice subsequently produced alioantibodies directed against the 
incompatible maternal type of IgG2~-globulin. 
In  one  series  of  experiments,  immunologic  tolerance  to  the  maternally 
derived "r-globulin was demonstrated to exist in the period before formation of 
spontaneous antibody. The state of tolerance was then lost, unless maintenance 
injections of foreign "r-globulin  were given. 
These  studies  demonstrate in a  natural situation that maternally derived 
foreign proteins can first induce a  state of immunological tolerance which is 
followed, after disappearance of the antigen, by a state of immunity. As such, 446  TOLERANCE  AND  IMMUNITY  TO  MATERNAL  IMMUNOGLOJ3ULINS 
this  parallels the  experimental  induction  of  tolerance  to  foreign proteins  by 
neonatal injections. 
The authors are indebted to Professor L. A. Herzenberg  for helpful discussions during the 
course of this work and during the preparation of this manuscript. 
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